Smart-ABI
Peripheral Artery Disease Diagnostic Test
TESTS BOTH ARMS, BOTH LEGS, BOTH POSTERIOR TIBIAL AND DORSALIS PEDIS ARTERIES
AUTOMATICALLY CALCULATES ABI AND SEVEN ADDITIONAL MEDICAL MARKERS
DISPLAYS ACTUAL BLOOD FLOW, SIX DIFFERENT PRESSURES AND TREND RESULTS OVER TIME
Performs Quantitative Analysis Enabling Early Detection of Peripheral Artery Disease (PAD)
and Peripheral Neuropathy (PN)
PAD is a major cost burden on
the U.S. Healthcare System
The Smart-ABI series
INSTANTLY
provides quantitative data physicians
can use to identify risk, provide
early detection, and initiate intervention
PROBLEM:
Symptoms don't manifest until 60% of the artery is occluded
75% of the United States population goes undiagnosed until the majority of the vessel is occluded
Manual ABI is subject to human error, cumbersome,
and is not reimbursable
Smart-ABI is:
-
EASY
-
IMMEDIATE
-
REIMBURSABLE
-
PATIENT/PHYSICIAN FRIENDLY REPORT
-
TRENDING ANALYSIS
-
COST EFFECTIVE
-
CONVENIENT
-
ACCURATE & REPRODUCIBLE
Smart-ABI eliminates:
-
RESCHEDULING
-
30-MINUTE TEST
-
CERTIFIED TECHNICIAN
-
HARD-TO-READ WAVEFORMS
-
WAITING FOR RESULTS
-
SPLIT FEES FOR REPORT READING
TEST. EDUCATE. PREVENT.
PAD Population Profile
age 50+ with history of diabetes
age 70+
age 50+ with history of smoking
It’s not about the number of patients, it’s about the type of patients. Left untreated, the 5 year mortality rate for these patients is over 30%.
It is critical this patient population is tested.